Sarcoidosis decisions — 2026

The Veteran's claim for a rating in excess of 50 percent for sarcoidosis with sleep apnea is denied. The Board finds that the evidence does not support a higher rating based on his condition requiring the use of a breathing assistance device, which is what he is currently evaluated under. As to TDIU, the Veteran's claim is granted as he is unable to work due to his service-connected sarcoidosis with sleep apnea since 2010.

The Veteran's appeal for chronic rhinitis and sarcoidosis was dismissed. The appeals for erectile dysfunction, skin condition, scar, fibromyalgia, headaches, bilateral hearing loss, CFS, dental abscess, visual acuity, memory loss condition, myocardial infraction, cardiovascular disease, sleep apnea, and diabetes mellitus were all dismissed.

The Veteran's claim for an earlier effective date and initial rating of 100 percent for AICD with congestive heart failure is granted, as is the claim for service connection for pulmonary hypertension associated with sarcoidosis. The Veteran also receives a 100 percent rating for sarcoidosis with chronic obstructive pulmonary disease.

The Board has granted the Veteran's claim for service connection for cardiac sarcoidosis, finding that the evidence is at least in approximate balance and supports a relationship between the Veteran's condition and his military service.

The Veteran's sarcoidosis is related to active military service, including as due to exposure to herbicide agents like Agent Orange. Service connection for sarcoidosis is granted.

The Veteran's claims for increased ratings and service connection are being remanded due to procedural errors, incomplete private treatment records, and the need for updated toxic exposure risk activities (TERA) medical opinions.

The Veteran's service-connected sarcoidosis and carpal tunnel syndrome prevented him from securing and following substantial gainful employment, leading to a total disability rating based on individual unemployability. Additionally, the Veteran has additional service-connected disabilities that meet the criteria for special monthly compensation under 38 U.S.C. § 1114(s).

The Board has granted reinstatement of the 30 percent disability rating for sarcoidosis effective January 22, 2018, as the reduction from 30 to 10 percent was improper based on a single examination and lack of clear evidence of sustained improvement.

The Veteran's claim for an earlier effective date for service connection for sarcoidosis was denied as there is no new and relevant evidence to support the request.

The Board has granted an effective date of September 1, 1991 for the award of entitlement to service connection for the cause of the Veteran's death due to apparent entitlement to DIC benefits.

The Board has remanded the Veteran's claims for service connection for a heart disability, increased ratings for sarcoidosis with pulmonary involvement and skin, and evaluations for bilateral visual field contraction due to inadequate examination findings.

The Veteran's respiratory disorder, including pulmonary hypertension, restrictive and obstructive lung diseases, sarcoidosis, and other conditions are remanded for further development to determine the nature and etiology of his service-connected disabilities.

The Veteran's appeals for service connection for fatigue and dizziness have been dismissed.,The Veteran's claims for service connection for tinnitus, sleep apnea, sarcoidosis, and hypertension are being remanded.